In terms of tracking the origins of the antitumor immune cells, we found that a central memory subset of tumor-infiltrating CD8+ T cells provided superior antitumor immunity compared with effector memory CD8+ T cells, similar to the findings of a comparative study by Klebanoff et al. The gene discussed is CD8A; the disease is neoplasm.